SURVEY OF AFRICAN AMERICAN PHYSICIANS AND PATIENTS

职位描述：(应聘者描述)招聘非裔美国人 第三阶段筛查和预防试验是困难的。我们的参与 作为SWOG-9217的研究站点：“前列腺癌的化学预防 非那雄胺(普罗卡)“已经证实了这一点。而最近的报道 强调最大限度减少少数群体参与障碍的重要性 为了增加招生人数，我们已经确定了重要的医生 有效阻止招生的担忧。一些非裔美国人 医生们认为前列腺癌预防试验(PCPT)是 构思拙劣，是种族主义的设计，将无法实现其 目标。此外，非裔美国人的患者担心被 被白人医生故意伤害。虽然这些恐惧是自由的 由患者向个别医护人员发声，无正式 已经对这些态度进行了记录。世界上的一些领导人 非洲裔美国医生群体认为，非洲裔美国人 没有参与试验的规划和设计，这些试验需要 招收非洲裔美国人作为研究对象。拟议的研究将 首先验证，然后使用旨在确定范围有多广的新调查 这些信念是坚守的。参与PCPT的患者将接受调查，因为 以及非洲裔美国人社区的成员，他们有资格 参加这项试验。美国国家医学会会员资格 协会(NMA)将在其年度会议上接受调查。我们会 确定多大比例的非裔美国医生 反对让他们的患者参加PCPT，如果潜在的受试者 都意识到了这种反对意见。我们将决定行为，知识， 以及对这些研究组参与临床试验的态度。 拟议的试点项目将提供独特的信息，可供使用 在未来的研究中，旨在测试扩大少数群体的策略 参与临床研究。

DESCRIPTION: (Applicant's Description) Recruitment of African-Americans to Phase III screening an d prevention trials is difficult. Our participation as a study site for SWOG-9217: "Chemoprevention of Prostate Cancer with Finasteride (Proscar)" has confirmed this. While recent reports have emphasized the importance of minimizing barriers to minority participation in order to increase enrollment, we have identified important physician concerns which effectively prevent enrollment. Some African-American physicians believe that the Prostate Cancer Prevention Trial (PCPT) was poorly conceived, is racist by design, and will fail to achieve its objectives. In addition, African-Americans patients fear being intentionally harmed by white physicians. While these fears are freely voiced by patients to individual health care workers, no formal documentation of these attitudes has been made. Some leaders in the African-American physician community hold the belief that African-Americans have not been involved in the planning and design of trials which require enrollment of African-Americans as study subjects. The proposed study will first validate then use new surveys designed to determine the how widely these beliefs are held. Patients involved in the PCPT will be surveyed, as well as members of the African-American Community who would be eligible for enrollment in this trial. The membership of the National Medical Association (NMA) will be surveyed at their annual meeting. We will determine what proportion of African-American physicians are actively opposed to enrolling their patients in the PCPT, and if potential subjects are aware of this opposition. We will determine the behavior, knowledge, and attitudes about participation in clinical trials of these study groups. The proposed pilot project will provide unique information which may be used in future studies, designed to test strategies to augment minority participation in clinical research.